As per PDF of Outcome of Board Meeting attached.

Date: 07th August, 2026 To, To, Manager - Listing Compliance Head of the Department, National Stock Exchange of India Department of Listing Operation, Limited ‘Exchange Plaza’. C-1, Block BSE Limited G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai 400001 Mumbai - 400 051 SCRIP Code: 544476 SYMBOL: JSLL Subject: Outcome of the Meeting of the Board of Directors of Jeena Sikho Lifecare Limited held on August 07, 2026 Ref: Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of Jeena Sikho Lifecare Limited ("the Company"), at its meeting held today i.e. Friday, 07th August, 2026 at the registered office situated in SCO 11 First Floor, Kalgidhar Enclave, Mohali, Zirakpur, Punjab, India, 140604 has inter alia, passed the resolutions as set out below: 1. Approval of Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026 along with Limited Review Report. The Board of Directors, on the recommendation of the Audit Committee, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, together with the Limited Review Reports issued by the Statutory Auditors thereon, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The said Financial Results along with the Limited Review Reports are enclosed herewith as Annexure-I. 2. Re-appointment of Mr. Karan Vir Bindra (DIN: 09283623) as an Independent Director of the Company, subject to approval of the shareholders. The Board of Directors, based on the recommendation of Nomination and Remuneration Committee and after due consideration, approved the re-appointment of Mr. Karan Vir Bindra (DIN: 09283623) as an Independent Non-Executive Director of the Company for a second term of five consecutive years with effect from 25th August 2026 to 24th August 2031, not liable to retire by rotation, subject to approval of members at the ensuing AGM. The Board is of the opinion that Mr. Karan Vir Bindra fulfils the conditions specified under the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for his re-appointment as an Independent Director of the Company and that he is independent of the management. Further, as per the requirement of the Circular No. LIST/COMP/14/2018-19 and SE/CML/2018/24 dated June 20, 2018 issued by the BSE and NSE respectively, we hereby confirm that Mr. Karan Vir Bindra is not debarred from holding the office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other such authority. Details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is enclosed as Annexure-II. 3. Re-appointment of Mrs. Bhavna Grover (DIN: 07557913) as a Whole-time Director of the Company, subject to approval of the shareholders. The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee and after due consideration, approved reappointment of Mrs. Bhavna Grover (DIN: 07557913) as Whole-Time Director and Key Managerial Personnel of the Company, liable to retire by rotation, for a period of five consecutive years with effect from 25th August 2026 to 24th August 2031, subject to approval of members at the ensuing AGM. Details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is enclosed as Annexure-III. 4. Re-Appointment of Mr. Manish Grover (DIN: 07557886), as Managing Director of the Company, subject to approval of the shareholders. The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee and after due consideration, approved reappointment of Mr. Manish Grover (DIN: 07557886) as Managing Director and Key Managerial Personnel of the Company, liable to retire by rotation, for a period of five consecutive years with effect from 25th August 2026 to 24th August 2031, subject to approval of members at the ensuing AGM. Details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is enclosed as Annexure-IV. The meeting of the Board of Directors of the Company commenced at 4:30 p.m. IST and concluded at 04:42 p.m. IST The above intimation is also being made available on the Company’s website at www.jeenasikho.com You are requested to take the above information on record and disseminate the same on your website. Thanking you, Yours faithfully, For Jeena Sikho Lifecare Limited Manish Grover Managing Director DIN: 07557886 Date: 07.08.2026 Place: Zirakpur, Punjab Walker Chandiok & Co LLP B-309, 3rd Floor, Elante Office Building, Industrial Area, Phase I, Chandigarh - 160 002 India T +91 172 403 8182 Independent Auditor’s Review Report on Standalone Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Jeena Sikho Lifecare Limited 1. We have reviewed the accompanying statement of standalone unaudited f inancial results (‘the Statement’) of Jeena Sikho Lifecare Limited (‘the Company’) for the qua rter ended 30 June 2026, being submitted by the Company pursuant to the requirements of R egulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’). 2. The Statement, which is the responsibility of the Company’s management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all [Showing first 8,000 characters — download PDF for full document]